These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11472755)

  • 1. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
    Watts GF; Barrett PH; Marais AD; Dane-Stewart CA; Martins IJ; Dimmitt SB; Redgrave TG
    Atherosclerosis; 2001 Aug; 157(2):519-23. PubMed ID: 11472755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
    Tremblay AJ; Lamarche B; Ruel I; Hogue JC; Bergeron J; Gagné C; Couture P
    Atherosclerosis; 2004 Feb; 172(2):367-73. PubMed ID: 15019548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity.
    Watts GF; Chan DC; Barrett PH; Martins IJ; Redgrave TG
    Clin Sci (Lond); 2001 Dec; 101(6):683-90. PubMed ID: 11724657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions.
    Carneiro MM; Miname MH; Gagliardi AC; Pereira C; Pereira AC; Krieger JE; Maranhão RC; Santos RD
    Atherosclerosis; 2012 Mar; 221(1):268-74. PubMed ID: 22257824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.
    Cabezas MC; de Bruin TW; Westerveld HE; Meijer E; Erkelens DW
    J Intern Med; 1998 Oct; 244(4):299-307. PubMed ID: 9797493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
    Redgrave TG; Watts GF; Martins IJ; Barrett PH; Mamo JC; Dimmitt SB; Marais AD
    J Lipid Res; 2001 May; 42(5):710-5. PubMed ID: 11352977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
    Dane-Stewart CA; Watts GF; Mamo JC; Barrett PH; Martins IJ; Dimmitt SB; Redgrave TG
    Eur J Clin Invest; 2002 Jul; 32(7):493-9. PubMed ID: 12153549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
    YU KC; Smith D; Yamamoto A; Kawaguchi A; Harada-Shiba M; Yamamura T; Mamo JC
    Clin Sci (Lond); 1997 Feb; 92(2):197-203. PubMed ID: 9059322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
    Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
    Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG
    J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
    Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
    Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
    Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia.
    Mamo JC; Smith D; Yu KC; Kawaguchi A; Harada-Shiba M; Yamamura T; Yamamoto A
    Eur J Clin Invest; 1998 May; 28(5):379-84. PubMed ID: 9650011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.
    Rubinsztein DC; Cohen JC; Berger GM; van der Westhuyzen DR; Coetzee GA; Gevers W
    J Clin Invest; 1990 Oct; 86(4):1306-12. PubMed ID: 2212015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
    Bowler A; Redgrave TG; Mamo JC
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of chylomicron-like lipid emulsions is increased in normal rabbits but not in heterozygous Watanabe heritable hyperlipidaemic rabbits following treatment with cholestyramine or pravastatin.
    Mamo JC; Bowler A; Redgrave TG; Elsegood CL
    Clin Exp Pharmacol Physiol; 1994 Sep; 21(9):687-94. PubMed ID: 7820948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice.
    Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG
    J Lipid Res; 2000 Feb; 41(2):205-13. PubMed ID: 10681404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test.
    Martins IJ; Tran JM; Redgrave TG
    J Nutr; 2002 Feb; 132(2):176-81. PubMed ID: 11823575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective plasma clearance of chylomicron-like lipid emulsions in Watanabe heritable hyperlipidemic rabbits.
    Mamo JC; Bowler A; Elsegood CL; Redgrave TG
    Biochim Biophys Acta; 1991 Feb; 1081(3):241-5. PubMed ID: 1998743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.